Long-term follow-up of symptomatic patients with lymphoplasmacytic lymphoma/Waldenström macroglobulinemia treated with the anti-CD52 monoclonal antibody alemtuzumab
- Resource Type
- Article
- Source
- In
Blood 14 July 2011 118(2):276-281 - Subject
- Language
- ISSN
- 0006-4971